Clinical Trial Update: The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial [Phase 3]

View source ↗

Summary

The OSCILLATE Phase 3 trial evaluating high-frequency oscillatory ventilation for acute respiratory distress syndrome was terminated early.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Canadian Critical Care Trials Group | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Status: TERMINATED